CRH Medical Corp (CRHM) Stock Rating Lowered by TheStreet

CRH Medical Corp (NYSEARCA:CRHM) was downgraded by investment analysts at TheStreet from a “b-” rating to a “c+” rating in a note issued to investors on Friday, August 4th.

A number of other brokerages have also weighed in on CRHM. Zacks Investment Research raised shares of CRH Medical Corp from a “sell” rating to a “hold” rating in a report on Tuesday, May 2nd. TD Securities lowered shares of CRH Medical Corp from a “buy” rating to a “hold” rating in a report on Tuesday, July 18th. National Bank Financial raised shares of CRH Medical Corp from a “sector perform” rating to an “outperform” rating in a report on Friday, August 4th. Canaccord Genuity reissued a “buy” rating and issued a $8.00 price target on shares of CRH Medical Corp in a report on Monday, July 17th. Finally, Royal Bank Of Canada raised shares of CRH Medical Corp from a “sector perform” rating to an “outperform” rating in a report on Friday, July 21st. Three analysts have rated the stock with a hold rating and five have given a buy rating to the company. The stock presently has an average rating of “Buy” and a consensus target price of $8.13.

Shares of CRH Medical Corp (NYSEARCA:CRHM) traded up 0.38% during trading on Friday, reaching $2.61. The company’s stock had a trading volume of 42,053 shares. CRH Medical Corp has a 12 month low of $2.14 and a 12 month high of $9.25. The company’s 50-day moving average is $2.55 and its 200-day moving average is $5.40.

TRADEMARK VIOLATION WARNING: This piece was reported by Community Financial News and is the property of of Community Financial News. If you are accessing this piece on another site, it was copied illegally and republished in violation of United States and international copyright and trademark law. The original version of this piece can be accessed at https://www.com-unik.info/2017/08/19/crh-medical-corp-nysearcacrhm-downgraded-by-thestreet-updated.html.

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Royal Bank of Canada grew its holdings in CRH Medical Corp by 523.9% during the 2nd quarter. Royal Bank of Canada now owns 176,487 shares of the company’s stock worth $1,006,000 after acquiring an additional 148,200 shares during the period. PDT Partners LLC grew its holdings in CRH Medical Corp by 176.4% during the 2nd quarter. PDT Partners LLC now owns 50,162 shares of the company’s stock worth $285,000 after acquiring an additional 32,013 shares during the period. Stifel Financial Corp grew its holdings in CRH Medical Corp by 16.4% during the 2nd quarter. Stifel Financial Corp now owns 1,546,154 shares of the company’s stock worth $8,814,000 after acquiring an additional 217,672 shares during the period. Advisor Group Inc. grew its holdings in CRH Medical Corp by 35.0% during the 2nd quarter. Advisor Group Inc. now owns 36,177 shares of the company’s stock worth $206,000 after acquiring an additional 9,389 shares during the period. Finally, Vanguard Group Inc. acquired a new stake in CRH Medical Corp during the 2nd quarter worth $150,000.

About CRH Medical Corp

CRH Medical Corporation is a Canada-based healthcare products and services company. The Company focused on providing physicians with services and products for the treatment of gastrointestinal diseases. The Company also provides anesthesiology services to gastroenterologists in the United States through its subsidiaries.

Analyst Recommendations for CRH Medical Corp (NYSEARCA:CRHM)

What are top analysts saying about CRH Medical Corp? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for CRH Medical Corp and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit